Arcadia Biosciences, Inc. (RKDA): Price and Financial Metrics


Arcadia Biosciences, Inc. (RKDA)

Today's Latest Price: $3.35 USD

0.05 (1.52%)

Updated Oct 27 6:55pm

Add RKDA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 28 in Agriculture

See all "A" rated Strong Buy stocks

RKDA Stock Summary

  • With a year-over-year growth in debt of 313.25%, Arcadia Biosciences Inc's debt growth rate surpasses 94.65% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Arcadia Biosciences Inc is reporting a growth rate of 504.6%; that's higher than 96.92% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for RKDA comes in at -69.64% -- higher than that of just 5.84% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Arcadia Biosciences Inc are TUFN, GWPH, PRO, ADMP, and AIRG.
  • Visit RKDA's SEC page to see the company's official filings. To visit the company's web site, go to www.arcadiabio.com.

RKDA Stock Price Chart Interactive Chart >

Price chart for RKDA

RKDA Price/Volume Stats

Current price $3.35 52-week high $6.63
Prev. close $3.30 52-week low $2.30
Day low $3.26 Volume 156,300
Day high $3.58 Avg. volume 220,256
50-day MA $3.10 Dividend yield N/A
200-day MA $3.74 Market Cap 35.85M

Arcadia Biosciences, Inc. (RKDA) Company Bio


Arcadia Biosciences, Inc. develops and commercializes agricultural products that enhance the environment and human health. It offers crop productivity and product quality traits for various crops. The company was founded in 2002 and is based in Davis, California.


RKDA Latest News Stream


Event/Time News Detail
Loading, please wait...

RKDA Latest Social Stream


Loading social stream, please wait...

View Full RKDA Social Stream

Latest RKDA News From Around the Web

Below are the latest news stories about Arcadia Biosciences Inc that investors may wish to consider to help them evaluate RKDA as an investment opportunity.

Arcadia Biosciences (RKDA) Expands Leadership Team with New Heads of Commercial Operations and Product Innovation

DAVIS, Calif., Sept. 17, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced two new appointments to its leadership team. Kevin Hodges has been…

PR Newswire | September 17, 2020

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q2 2020 Results - Earnings Call Transcript

Arcadia Biosciences, Inc. (RKDA) Q2 2020 Earnings Conference Call August 13, 2020 04:30 PM ET Company Participants Matthew Plavan - President & CEO Pamela Haley - CFO Randy Shultz - Chief Technology Officer Conference Call Participants Ben Klieve - National Securities Corporation Steven Ralston - Zachs Robert Smith - Center...

SA Transcripts on Seeking Alpha | August 14, 2020

Arcadia Biosciences EPS misses by $0.45, misses on revenue

Arcadia Biosciences (RKDA): Q2 GAAP EPS of -$1.04 misses by $0.45.Revenue of $0.28M (+40.0% Y/Y) misses by $1.58M.Press Release...

Seeking Alpha | August 13, 2020

Arcadia Biosciences Announces Collaboration with Corner Foods to Commercialize GoodWheat™ Technology

DAVIS, Calif., Aug. 6, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the execution of a term sheet to collaborate with Corner Foods, an…

PR Newswire | August 6, 2020

Arcadia Biosciences Announces Warrant Exercise Transaction to Generate $2.5 Million in Gross Proceeds

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into a definitive agreement with an institutional investor for the exercise of certain existing warrants to purchase up to an aggregate of 641,416 shares of common stock at a reduced exercise price of $3.975 per share. Additionally, Arcadia has agreed to issue to the investor new unregistered warrants to purchase up to an aggregate of 641,416 shares of common stock shares at an exercise price of $3.85 per share and with an exercise period of five and one-half years from the date of issuance. The closing of the transaction is expected to occur on or about July 8, 2020, subject to the satisfaction ...

Yahoo | July 6, 2020

Read More 'RKDA' Stories Here

RKDA Price Returns

1-mo 21.82%
3-mo -7.20%
6-mo -15.83%
1-year -32.32%
3-year -42.24%
5-year -94.02%
YTD -38.87%
2019 72.87%
2018 -42.36%
2017 -70.11%
2016 -69.74%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8085 seconds.